Phytomedicine: A Treasure of Pharmacologically Active Products from Plants aims to present updated knowledge of plant-based medicines in terms of their research and development, production, and utilization, from the viewpoint of sustainability and by using the latest technologies. The book explores different phytometabolites on a mass scale, coupled with the efficacy, performance and applicability on target organisms to treat curable and fatal diseases.
Readers will find a coherent package of phytotherapeutic information regarding inclusive assortment of research based, scientific amplitude of metabolites from the plant world encompassing various action plans. Information is presented sequentially regarding phytochemistry, biological activity and the serviceable aspects of bioactive compounds. The book also addresses various advancements and achievements of novel drugs from plants using molecular and enzymatic activities, and various technological tools in an ecofriendly fashion.
1. Phytomedicine - p. iii 2. Cover - p. iii 3. Title Page - p. iii 4. Copyright - p. iv 5. Table of Contents - p. iii 6. Contributors - p. xix 7. About the editors - p. xxv 8. Foreword - p. xxvii 9. Preface - p. xxxiii 10. About the book - p. xxxv 11. Chapter 1 Phytomedicines: Diversity, extraction, and conservation strategies - p. 1 12. Chapter 2 Biotechnological approaches for conservation of medicinal plants - p. 35 13. Chapter 3 Plant biotechnologies for processing raw products in phytomedicines - p. 59 14. Chapter 4 Phytomedicine and phytonanocomposites—An expanding horizon - p. 95 15. Chapter 5 Herbal medicine: Old practice and modern perspectives - p. 149 16. Chapter 6 Bioactive compounds obtained from plants, their pharmacological applications and encapsulation - p. 181 17. Chapter 7 Medicinal plants and their traditional uses in different locations - p. 207 18. Chapter 8 Perspectives of phytotherapeutics: Diagnosis and cure - p. 225 19. Chapter 9 Ethnobotanical perspectives in the treatment of communicable and noncommunicable diseases - p. 251 20. Chapter 10 Health benefits of bioactive compounds from microalgae - p. 291 21. Chapter 11 Some special diets used as neutraceuticals in Unani system of medicine with modern aspects - p. 321 22. Chapter 12 Phytomedicines: Synergistic and antagonistic phytometabolites-drug interactions - p. 343 23. Chapter 13 Role of genetically modified plant repository in biopharmaceutical industries - p. 377 24. Chapter 14 Role of phytomedicines in metabolic disorders - p. 389 25. Chapter 15 Artemisia amygdalina Decne.: A rich repository of pharmacologically vital phytoconstituents - p. 409 26. Chapter 16 Bioprospecting of endophytic fungi for antibacterial and antifungal activities - p. 427 27. Chapter 17 Bioprospecting appraisal of Himalayan pindrow fir for pharmacological applications - p. 461 28. Chapter 18 Date palm (Phoenix dactylifera L.) secondary metabolites: Bioactivity and pharmaceutical potential - p. 483 29. Chapter 19 The inhibitory role of the metabolites of Moringa oleifera seeds in cancer cells by apoptosis and cell cycle arrest activation - p. 533 30. Chapter 20 The medicinal properties of Olax subscorpioidea - p. 555 31. Chapter 21 Phytotherapeutic agents for neurodegenerative disorders: A neuropharmacological review - p. 581 32. Chapter 22 Hepatotoxicity: Its physiological pathways and control measures using phyto-polyphenols - p. 621 33. Chapter 23 Nanosized delivery systems for plant-derived therapeutic compounds and their synthetic derivative for cancer therapy - p. 655 34. Chapter 24 Potential antioxidative response of bioactive products from Ganoderma lucidum and Podophyllum hexandrum - p. 677 35. Chapter 25 Phytomedicine and the COVID-19 pandemic - p. 693 36. Chapter 26 Phytopharmaceutical marketing: A case study of USPs used for phytomedicine promotion - p. 709 37. Index - p. 725
Phytomedicine: A Treasure of Pharmacologically Active Products from Plants aims to present updated knowledge of plant-based medicines in terms of their research and development, production, and utilization, from the viewpoint of sustainability and by using the latest technologies. The book explores different phytometabolites on a mass scale, coupled with the efficacy, performance and applicability on target organisms to treat curable and fatal diseases.
Readers will find a coherent package of phytotherapeutic information regarding inclusive assortment of research based, scientific amplitude of metabolites from the plant world encompassing various action plans. Information is presented sequentially regarding phytochemistry, biological activity and the serviceable aspects of bioactive compounds. The book also addresses various advancements and achievements of novel drugs from plants using molecular and enzymatic activities, and various technological tools in an ecofriendly fashion.
1. Phytomedicine - p. iii 2. Cover - p. iii 3. Title Page - p. iii 4. Copyright - p. iv 5. Table of Contents - p. iii 6. Contributors - p. xix 7. About the editors - p. xxv 8. Foreword - p. xxvii 9. Preface - p. xxxiii 10. About the book - p. xxxv 11. Chapter 1 Phytomedicines: Diversity, extraction, and conservation strategies - p. 1 12. Chapter 2 Biotechnological approaches for conservation of medicinal plants - p. 35 13. Chapter 3 Plant biotechnologies for processing raw products in phytomedicines - p. 59 14. Chapter 4 Phytomedicine and phytonanocomposites—An expanding horizon - p. 95 15. Chapter 5 Herbal medicine: Old practice and modern perspectives - p. 149 16. Chapter 6 Bioactive compounds obtained from plants, their pharmacological applications and encapsulation - p. 181 17. Chapter 7 Medicinal plants and their traditional uses in different locations - p. 207 18. Chapter 8 Perspectives of phytotherapeutics: Diagnosis and cure - p. 225 19. Chapter 9 Ethnobotanical perspectives in the treatment of communicable and noncommunicable diseases - p. 251 20. Chapter 10 Health benefits of bioactive compounds from microalgae - p. 291 21. Chapter 11 Some special diets used as neutraceuticals in Unani system of medicine with modern aspects - p. 321 22. Chapter 12 Phytomedicines: Synergistic and antagonistic phytometabolites-drug interactions - p. 343 23. Chapter 13 Role of genetically modified plant repository in biopharmaceutical industries - p. 377 24. Chapter 14 Role of phytomedicines in metabolic disorders - p. 389 25. Chapter 15 Artemisia amygdalina Decne.: A rich repository of pharmacologically vital phytoconstituents - p. 409 26. Chapter 16 Bioprospecting of endophytic fungi for antibacterial and antifungal activities - p. 427 27. Chapter 17 Bioprospecting appraisal of Himalayan pindrow fir for pharmacological applications - p. 461 28. Chapter 18 Date palm (Phoenix dactylifera L.) secondary metabolites: Bioactivity and pharmaceutical potential - p. 483 29. Chapter 19 The inhibitory role of the metabolites of Moringa oleifera seeds in cancer cells by apoptosis and cell cycle arrest activation - p. 533 30. Chapter 20 The medicinal properties of Olax subscorpioidea - p. 555 31. Chapter 21 Phytotherapeutic agents for neurodegenerative disorders: A neuropharmacological review - p. 581 32. Chapter 22 Hepatotoxicity: Its physiological pathways and control measures using phyto-polyphenols - p. 621 33. Chapter 23 Nanosized delivery systems for plant-derived therapeutic compounds and their synthetic derivative for cancer therapy - p. 655 34. Chapter 24 Potential antioxidative response of bioactive products from Ganoderma lucidum and Podophyllum hexandrum - p. 677 35. Chapter 25 Phytomedicine and the COVID-19 pandemic - p. 693 36. Chapter 26 Phytopharmaceutical marketing: A case study of USPs used for phytomedicine promotion - p. 709 37. Index - p. 725
